Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review

•Dupilumab, as an IL4Rα antagonist, showed a beneficial effect on BP.•We reported the clinical data for nine BP patients treated with dupilumab.•Previous literature describing the use of dupilumab for BP was summarized. Bullous pemphigoid is an autoimmune blistering disease that affects the elderly...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International immunopharmacology 2023-03, Vol.116, p.109788-109788, Article 109788
Hauptverfasser:	Liang, Junqin, Abulikemu, Kailibinuer, Maolidan, Hu, Fengxia, Zhao, Juan, Qiu, Yun, Wang, Qian, Sang, Yingbing, Hong, Yongzhen, Kang, Xiaojing
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones Aged Antibodies, Monoclonal, Humanized - therapeutic use Autoimmune Diseases Bullous pemphigoid Child Child, Preschool Dupilumab Humans Interleukin 13 Interleukin 4 Pemphigoid, Bullous - drug therapy Retrospective Studies Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!